Blood cell values in treated and control rats
. | White blood cells 103/μL . | Hematocrit % . | Hemoglobin g/dL . | Platelets 103/μL . |
---|---|---|---|---|
Saline control (n = 2) | 8.9 (± 2.6) | 46.2 (± 11.5) | 16.2 (± 0.8) | 592 (± 102) |
DNA control (n = 2) | 8.5 (± 1.9) | 46.3 (± 02.9) | 16.1 (± 0.5) | 575 (± 73) |
eGFP control (n = 2) | 8.9 (± 2.2) | 46.4 (± 1.6) | 16.1 (± 0.8) | 585 (± 87) |
EPO low dose (n = 2) | 8.9 (± 2.2)* | 52.7 (± 1.3)† | 18.0 (± 0.8)‡ | 585 (± 87)* |
EPO high dose (n = 4) | 8.5 (± 3.1)* | 68.5 (± 2.1)† | 21.6 (± 2.6)† | 571 (± 95)* |
. | White blood cells 103/μL . | Hematocrit % . | Hemoglobin g/dL . | Platelets 103/μL . |
---|---|---|---|---|
Saline control (n = 2) | 8.9 (± 2.6) | 46.2 (± 11.5) | 16.2 (± 0.8) | 592 (± 102) |
DNA control (n = 2) | 8.5 (± 1.9) | 46.3 (± 02.9) | 16.1 (± 0.5) | 575 (± 73) |
eGFP control (n = 2) | 8.9 (± 2.2) | 46.4 (± 1.6) | 16.1 (± 0.8) | 585 (± 87) |
EPO low dose (n = 2) | 8.9 (± 2.2)* | 52.7 (± 1.3)† | 18.0 (± 0.8)‡ | 585 (± 87)* |
EPO high dose (n = 4) | 8.5 (± 3.1)* | 68.5 (± 2.1)† | 21.6 (± 2.6)† | 571 (± 95)* |